Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Li Wenchao,Blessin Niclas C.,Simon Ronald^ORCID,Kluth Martina,Fischer Kristine,Hube-Magg Claudia,Makrypidi-Fraune Georgia,Wellge Björn,Mandelkow Tim,Debatin Nicolaus F.,Pott Laura,Höflmayer Doris,Lennartz Maximilian,Sauter Guido,Izbicki Jakob R.,Minner Sarah,Büscheck Franziska,Uhlig Ria,Dum David,Krech Till,Luebke Andreas M.,Wittmer Corinna,Jacobsen Frank,Burandt Eike,Steurer Stefan,Wilczak Waldemar,Hinsch Andrea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5111-1.pdf

Reference44 articles.

1. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9(1):15–27.

2. Roman E, Smith AG. Epidemiology of lymphomas. Histopathology. 2011;58(1):4–14.

3. Erkilic S, Erbagci Z, Kocer NE, Bayazit YA, Camci C. Cutaneous involvement in Hodgkin's lymphoma: report of two cases. J Dermatol. 2004;31(4):330–4.

4. Diehl V, Thomas RK, Re D. Part II: Hodgkin's lymphoma--diagnosis and treatment. Lancet Oncol. 2004;5(1):19–26.

5. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311–9.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT;Onco;2024-07-01

2. Emerging immunotherapies in the Hodgkin lymphoma armamentarium;Expert Opinion on Emerging Drugs;2024-05-06

3. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-04

4. Targeting TIGIT for cancer immunotherapy: recent advances and future directions;Biomarker Research;2024-01-16

5. TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas;American Journal of Surgical Pathology;2023-12-22